How Has The Adult Vaccines Market Size Evolved Historically?
The adult vaccines market has seen considerable growth due to a variety of factors.
• The market size of adult vaccines has seen solid growth in the past few years. It is projected to rise from $22.82 billion in 2024 to $24.49 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.3%. The growth during the historic period was largely driven by factors such as an increasing older population, government-run vaccination initiatives, heightened awareness about preventative healthcare, advancements and innovation in vaccine development, and public health awareness campaigns.
What is the Forecasted Market Size and CAGR for the Adult Vaccines Market?
The Adult Vaccines market is expected to maintain its strong growth trajectory in upcoming years.
• The size of the adult vaccine market is looking towards a robust increase in the upcoming years, potentially reaching a value of $35.22 billion by 2029 with a compound annual growth rate (CAGR) of 9.5%.
The reasons for this projected rise during the prediction span can be accredited to the development of novel infectious risks, heightened attention towards immunization lists, the growing problem of antimicrobial resistance, worldwide initiatives for dealing with pandemics, a shift in preference for personalized vaccines, and an increased emphasis on maternal immunization. Notable trends expected during this period comprise the integration of digital health, advancements in vaccine creation technology, partnerships between governmental bodies and pharmaceutical corporations, improvements in vaccine distribution methods, and wider-reaching immunization campaigns.
What Key Factors and Trends Are Driving The Growth Adult Vaccines Market?
The escalating occurrence of highly infectious diseases is propelling the advancement of the adult vaccine market. These are diseases that transmit from one person to another. Vaccinations assist an individual in building resistance against such diseases, making these an efficient tool in combating infections. As an example, per the data released by the Centers for Disease Control and Prevention - a US-based national public health organization, in March 2023, 8,300 instances of tuberculosis were reported in the United States in 2022, higher than the 7,874 cases registered in 2021. The prevalence of TB in 2022 saw a slight rise to 2.5 per 100,000 individuals from 2.4 the previous year. Owing to these factors, the escalating prevalence of infectious diseases is facilitating the growth of the adult vaccine market.
What Are The Market Segments In The Adult Vaccines Market?
The adult vaccines market covered in this report is segmented –
1) By Vaccine Type: Monovalent, Multivalent
2) By Technology: Live Attenuated Vaccines, Inactivated Viral Or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines
3) By Application: Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis
4) By End Users: Healthcare Firms, Hospitals
Subsegments:
1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines
2) By Multivalent: Combination Vaccines, Multi-Antigen Vaccines
Pre-Book The Adult Vaccines Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Shaping The Adult Vaccines Market?
The introduction of innovative products is a major trend that is emerging in the adult vaccines market, with leading companies launching new products to maintain their market standing. For example, in August 2022, GSK, a biopharma company based in the UK, partnered with IQVIA, a global leader in advanced analytics, technology solutions, and clinical research services from India, to introduce Vaccine Track. This data trend platform aims to boost adult vaccination in communities across the country by offering regular and pertinent data on trends to bolster public health initiatives.
Who Are the Key Players In The Adult Vaccines Market?
Major companies operating in the adult vaccines market include:
• GlaxoSmithKline PLC
• Merck & Co
• Sanofi Pasteur
• Pfizer Inc
• Commonwealth Serum Laboratories Limited
• Johnson & Johnson
• Serum Institute of India
• AstraZeneca PLC
• Novartis AG
• Protein Sciences Corporation
• Emergent BioSolutions Inc.
• Bavarian Nordic A/S
• Dynavax Technologies Corporation
• Novavax Inc
• Medimmune LLC
• BioNTech SE
• Moderna
• Inovio Pharmaceuticals
• Sinovac
• Valneva Se
• Biological E Limited
• Panacea Biotec
• Shenzhen Kangtai Biological Products
• Beijing Tiantan Biological Products
• Hualan Biological Engineering
• Chengdu Institute of Biological Products
• Bharat Biotech International Limited
• Takeda Pharmaceutical Company Limited
What Are The Regional Insights Into The Adult Vaccines Market?
North America was the largest region in the adult vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the adult vaccines market during the forecast period. The regions covered in the adult vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
